Please assess the completion status of the following clinical trial:

Trial Title: Itraconazole for Fungal Sensitive Chronic Rhinosinusitis With Nasal Polyps

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Meet criteria for diagnosis of CRS with nasal polyps undergoing medically indicated sinus surgery~Exclusion Criteria:~* cystic fibrosis~* aspirin exacerbated respiratory disease~* uncontrolled or unstable chronic diseases such as uncontrolled diabetes~* active or history of cancer~* HIV positive~* history of liver or kidney disease~* history of disease with effects on immune system~* pregnant~* allergy to triazole antifungals

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): 2 capsules by mouth twice a day for 24 weeks
- Itraconazole (Type: ACTIVE_COMPARATOR): Two 100mg capsules by mouth twice a day for 24 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).